Impact of immigration status on survival amongst early-stage (1&2) HER2 positive and triple-negative breast cancer patients in Ontario, Canada.
Abstract
e12512 Background: This study explored death from breast cancer and death from other causes amongst women with stages 1 and 2 her2 positive and triple-negative breast cancer (BC) by immigration status. Methods: We identified women aged 18-75 diagnosed with BC in Ontario from January 1 st, 2012, to Dec 31 st, 2019, and followed them up to 31 st Dec, 2023. We stratified them into immigrants and long-term residents according to the Immigration, Refugee, and Citizenship Canada Permanent Resident (CIC) database. Using linked administrative data sources, we extracted information on the date of diagnosis, molecular subtype, death due to breast cancer, and death due to all other causes. Using competing risks regression (Fine & Gray method), we analyzed the influence of immigration on breast cancer survival, adjusting for age, molecular subtype, stage, resource utilization, and marginalization by ethnic concentration quintile and calculated the sub-distribution hazard ratios (SHR). Results: We included 8,927 women, 1,617 immigrants (540 with TNBC, and 1,077 had her2 positive BC), and 7,310 long-term residents (2,724 with TNBC, and 4586 had her2 positive). The mean age was 55.75 (SD 10.81). Most immigrants lived in areas comprising the highest quintile of ethnic concentration, indicating the highest level of marginalization. At the end of the follow-up period, 557 (6.2%) had died from breast cancer, while 475 (5.3%) had died from all other causes. Conclusions: Immigration status does not increase the risk of death from breast cancer or death from other causes among women with stage 1 and 2 Her 2 positive or triple-negative breast cancer in Ontario. Multivariable Cox proportional hazards regression with sub-distribution hazards. Breast cancer deaths Deaths from other causes p-value SHR 95% ConfidenceLimit p-value SHR 95% Confidence Limit Immigrants vs long-term residents 0.68 1.05 0.82 1.35 0.58 0.92 0.67 1.25 Her2 positive vs TNBC <.0001 0.35 0.30 0.42 0.36 0.92 0.76 1.10 Ethnic concentration quintileQuintile 1 (lowest)(ref)Quintile 2Quintile 3Quintile 4Quintile 5 0.620.330.350.58 1.070.870.880.93 0.820.660.660.70 1.401.151.161.22 0.200.870.010.09 0.830.980.680.77 0.630.740.500.57 1.101.280.911.05 For 1-year increase in age <.0001 1.02 1.01 1.03 <.0001 1.06 1.05 1.08
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (6)
Omolara Aminat Fatiregun
Lagos State University College of Medicine/Teaching Hospital, Lagos, Lagos, Nigeria
Rinku Sutradhar
5ICES, Toronto, Canada
Sho Podolsky
3Institute for Clinical Evaluative Sciences, Toronto, Canada
Andrea Eisen
Department of Medical Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, ON, Canada
Lawrence Frank Paszat
Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
Eileen Rakovitch
Sunnybrook Health Sciencies, Toronto, ON, Canada